Literature DB >> 8137970

Identification of main risk factors for tubal infertility.

L Bahamondes1, J G Bueno, E Hardy, S Vera, E Pimentel, M Ramos.   

Abstract

OBJECTIVE: To determine the relationship between some reproductive variables and infertility caused by tubal obstruction.
DESIGN: A retrospective, case-control study.
SETTING: A tertiary care university hospital that is a referral center for infertility patients. PARTICIPANTS: Subjects were interviewed between March 1990 and December 1991. Cases were 215 consecutively recruited infertile women with either evidence of tubal obstruction found at laparoscopy or hydrosalpinx diagnosed by hysterosalpingography. Women with a history of surgical sterilization were excluded. Controls, selected in the same hospital, were women in the puerperium who had no history of infertility. Two controls were matched by age at the time of tubal obstruction diagnosis to each case.
RESULTS: History of pelvic surgery and use of alcohol were significantly associated with the risk of infertility caused by tubal obstruction. The use of barrier, oral, and medroxyprogesterone acetate (MPA) contraceptives was associated with a protective effect. When only women with secondary infertility were analyzed, history of pelvic surgery and number of lifetime sexual partners were significant risk factors, and the previous use of oral contraceptives was the only protective factor.
CONCLUSIONS: History of pelvic surgery was the most important risk factor for tubal infertility. All precautions must be taken to avoid infection and adhesion formation when pelvic surgery is performed. In addition, women can be protected from tubal infertility by using barrier, oral, or MPA contraceptive methods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137970

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  High incidence of tubal dysfunction is determined by laparoscopy in cases with positive Chlamydia trachomatis antibody despite negative finding in prior hysterosalpingography.

Authors:  Hisahiko Hiroi; Toshihiro Fujiwara; Manabu Nakazawa; Yutaka Osuga; Mikio Momoeda; Koji Kugu; Tetsu Yano; Osamu Tsutsumi; Yuji Taketani
Journal:  Reprod Med Biol       Date:  2007-02-16

Review 2.  Alcohol use disorders in primary care: do gender-specific differences exist?

Authors:  Rebecca S Brienza; Michael D Stein
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

3.  Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population.

Authors:  Aykut Bayrak; Djana Harp; Peyman Saadat; Eliran Mor; Richard J Paulson
Journal:  J Assist Reprod Genet       Date:  2006-07-22       Impact factor: 3.412

4.  Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy.

Authors:  T K Jensen; N H Hjollund; T B Henriksen; T Scheike; H Kolstad; A Giwercman; E Ernst; J P Bonde; N E Skakkebaek; J Olsen
Journal:  BMJ       Date:  1998-08-22

Review 5.  Treating female infertility and improving IVF pregnancy rates with a manual physical therapy technique.

Authors:  Belinda F Wurn; Lawrence J Wurn; C Richard King; Marvin A Heuer; Amanda S Roscow; Eugenia S Scharf; Jonathan J Shuster
Journal:  MedGenMed       Date:  2004-06-18

Review 6.  Medical risks for women who drink alcohol.

Authors:  K A Bradley; S Badrinath; K Bush; J Boyd-Wickizer; B Anawalt
Journal:  J Gen Intern Med       Date:  1998-09       Impact factor: 5.128

7.  The Diagnostic Properties of Medical History in the Diagnosis of Tubal Pathology among Subfertile Patients.

Authors:  Egle Tvarijonaviciene; Ruta Jolanta Nadisauskiene; Kristina Jariene; Valdemaras Kruminis
Journal:  ISRN Obstet Gynecol       Date:  2012-01-22

8.  Preovulatory uterine flushing with saline as a treatment for unexplained infertility: a randomised controlled trial protocol.

Authors:  Sarah Maheux-Lacroix; Sylvie Dodin; Lynne Moore; Emmanuel Bujold; Jessica Lefebvre; Marie-Ève Bergeron
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.